
Loan & Debt22 Sept 2026, 06:02 pm
Ishita Drugs secures ₹11.75 Cr loan from HDFC Bank for plant upgrade
AI Summary
Ishita Drugs & Industries Ltd has entered into a loan agreement with HDFC Bank Limited for a total of ₹11.75 Crore. The loan comprises a ₹9.75 Crore Term Loan and a ₹2.00 Crore Working Capital Facility. The purpose of this financing is to fund the upgradation project of the company's manufacturing facility located in Sanand, Ahmedabad, ensuring compliance with the Revised Schedule M. The loan is secured by a first charge on the immovable and movable assets of the Sanand facility. The agreement was executed on September 22, 2026. The transaction is not a related party transaction, and no special rights have been granted to HDFC Bank.
Key Highlights
- Ishita Drugs secured ₹11.75 Cr loan from HDFC Bank.
- Funds will upgrade Sanand manufacturing facility.
- Upgrade ensures compliance with Revised Schedule M.
- Loan includes term loan and working capital facility.
- Secured by first charge on Sanand facility assets.
Price Impact
More from ISHITADR